Effect of Repeated Administration of ɣ-Valerolactone (GVL) and GHB in the Mouse: Neuroadaptive Changes of the GHB and GABAergic System
Background: Gamma-hydroxybutyric acid (GHB) at low dosages has anxiolytic effects and promotes REM sleep and low-wave deep sleep. In the U.S., the legal form of GHB is prescribed to adults suffering from narcolepsy-associated cataplexy; the sodium salt of GHB is reserved for alcohol-addiction treatm...
Main Authors: | Paolo Frisoni, Giorgia Corli, Sabrine Bilel, Micaela Tirri, Laura Camilla Gasparini, Letizia Alfieri, Margherita Neri, Fabio De-Giorgio, Matteo Marti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/9/1225 |
Similar Items
-
Gamma-Hydroxybutyrate (GHB) Withdrawal
by: Everett, Worth W
Published: (2001-04-01) -
Intoxication with GHB/GBL: characteristics and trends from ambulance-attended overdoses
by: Desiree Madah-Amiri, et al.
Published: (2017-09-01) -
GHB: a life-threatening drug complications and outcome of GHB detoxification treatment—an observational clinical study
by: Peter Neu, et al.
Published: (2023-10-01) -
Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry Assay for Determination of Endogenous GHB and GHB-Glucuronide in Nails
by: Francesco Paolo Busardò, et al.
Published: (2018-10-01) -
Characterization of the GHB Withdrawal Syndrome
by: Casper J. H. Wolf, et al.
Published: (2021-05-01)